The role of spironolactone in the treatment of patients with refractory hypertension
Open Access
- 1 April 2002
- journal article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 15 (4) , 333-339
- https://doi.org/10.1016/s0895-7061(01)02342-1
Abstract
Background:. Hypertension is resistant to pharmacologic therapy in 5% to 10% of patients. The current study tested whether addition of spironolactone tKeywords
This publication has 20 references indexed in Scilit:
- Screening for primary aldosteronism without discontinuing hypertensive medications: Plasma aldosterone-renin ratioPublished by Elsevier ,2001
- Hypertension detection, treatment and control: A call to action for cardiovascular specialistsJournal of the American College of Cardiology, 1999
- Prognostic Value of Ambulatory Blood Pressure Monitoring in Refractory HypertensionHypertension, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- Blood Pressure and End-Stage Renal Disease in MenNew England Journal of Medicine, 1996
- Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US PopulationHypertension, 1995
- Prevalence of Hypertension in the US Adult PopulationHypertension, 1995
- Refractory HypertensionNew England Journal of Medicine, 1992
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextPublished by Elsevier ,1990
- Prevalence of drug resistant hypertension.Hypertension, 1988